Treatments Available for Heart Failure Caused by Onglyza

New scientific evidence shows using the medication Onglyza, a popular type 2 diabetes drug, increases a user’s risk for heart failure. Clinical trials have confirmed that diabetic individuals taking Onglyza, especially those who have existing major organ complications, dramatically increase their possibility of experiencing heart failure. These findings have recently prompted the Food and Drug Administration (FDA) to require the makers of Onglyza to include the potential threat of heart failure on the drug’s warning…

Read More »